BE2018C035I2 - - Google Patents

Info

Publication number: BE2018C035I2
Authority: BE; Belgium

Application number

BE2018C035C

Other languages

French (fr)

Original Assignee

Glaxosmithkline Biologicals Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-03

Filing date

2018-09-20

Publication date

2025-09-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE2018C035(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-09-20 Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa

2025-09-05 Publication of BE2018C035I2 publication Critical patent/BE2018C035I2/fr

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/25—Varicella-zoster virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Biotechnology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

BE2018C035C 2005-03-03 2018-09-20 BE2018C035I2 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0504436.7A GB0504436D0 (en)	2005-03-03	2005-03-03	Vaccine

Publications (1)

Publication Number	Publication Date
BE2018C035I2 true BE2018C035I2 (en)	2025-09-05

Family

ID=34430592

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE2018C035C BE2018C035I2 (en)	2005-03-03	2018-09-20

Country Status (36)

Country	Link
US (3)	US20080171079A1 (en)
EP (4)	EP1858917B8 (en)
JP (2)	JP5420842B2 (en)
KR (2)	KR20140006115A (en)
CN (2)	CN101189254B (en)
AR (2)	AR052498A1 (en)
AU (1)	AU2006222225B2 (en)
BE (1)	BE2018C035I2 (en)
BR (1)	BRPI0607840B1 (en)
CA (2)	CA2600905C (en)
CY (5)	CY1116108T1 (en)
DK (4)	DK2281830T3 (en)
EA (1)	EA011884B1 (en)
ES (4)	ES2675054T3 (en)
FR (1)	FR18C1040I2 (en)
GB (1)	GB0504436D0 (en)
HR (4)	HRP20150142T1 (en)
HU (4)	HUE038468T2 (en)
IL (1)	IL185442A (en)
LT (4)	LT2281831T (en)
LU (1)	LUC00087I2 (en)
MA (1)	MA29714B1 (en)
MX (2)	MX2007010626A (en)
MY (1)	MY148464A (en)
NL (1)	NL300951I2 (en)
NO (2)	NO341841B1 (en)
NZ (1)	NZ561075A (en)
PE (2)	PE20100658A1 (en)
PL (4)	PL2281830T3 (en)
PT (4)	PT2281831T (en)
SI (4)	SI2281831T1 (en)
TR (2)	TR201809393T4 (en)
TW (1)	TWI403517B (en)
UA (1)	UA94900C2 (en)
WO (1)	WO2006094756A2 (en)
ZA (1)	ZA200707144B (en)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0504436D0 (en) *	2005-03-03	2005-04-06	Glaxosmithkline Biolog Sa	Vaccine
TWI457133B (en)	2005-12-13	2014-10-21	Glaxosmithkline Biolog Sa	Novel composition
CA2729011A1 (en) *	2007-07-19	2009-01-22	Novavax, Inc.	Varicella zoster virus-virus like particles (vlps) and antigens
FR2952825B1 (en)	2009-11-24	2012-05-25	Goaster Jacqueline Le	USE OF A VZV / HSV3 VIRUS VACCINE FOR TREATING HERPETIC INFECTIONS WITH HSV1 VIRUS AND / OR HSV2 VIRUS
SI2591114T1 (en)	2010-07-06	2016-10-28	Glaxosmithkline Biologicals S.A.	Immunisation of large mammals with low doses of rna
ES2646669T3 (en)	2010-07-06	2017-12-14	Glaxosmithkline Biologicals Sa	Procedures for increasing an immune response by providing RNA
AU2011276234B2 (en)	2010-07-06	2016-02-25	Glaxosmithkline Biologicals S.A.	Liposomes with lipids having an advantageous pKa- value for RNA delivery
UA112970C2 (en) *	2010-08-05	2016-11-25	Мерк Шарп Енд Доме Корп.	INITIATED WINDOW ISLAND VIRUS, METHOD OF ITS RECEIVING AND APPLICATION
WO2012031043A1 (en)	2010-08-31	2012-03-08	Novartis Ag	Pegylated liposomes for delivery of immunogen-encoding rna
EP3520813B1 (en)	2010-10-11	2023-04-19	GlaxoSmithKline Biologicals S.A.	Antigen delivery platforms
EP3854413A1 (en)	2011-07-06	2021-07-28	GlaxoSmithKline Biologicals SA	Immunogenic combination compositions and uses thereof
US9849066B2 (en)	2013-04-24	2017-12-26	Corning Incorporated	Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
TW201601750A (en) *	2013-10-03	2016-01-16	Nitto Denko Corp	Injectable vaccine composition
JP6499420B2 (en) *	2014-11-13	2019-04-10	公益財団法人ヒューマンサイエンス振興財団	Vaccines and infection protection kits
BE1022523B1 (en) *	2014-12-18	2016-05-20	Glaxosmithkline Biologicals Sa	VACCINATION
CN107106675A (en) *	2014-12-18	2017-08-29	葛兰素史密丝克莱恩生物有限公司	Vaccine inoculation
MD3718565T2 (en)	2015-10-22	2022-09-30	Modernatx Inc	Respiratory virus vaccines
WO2017070601A1 (en) *	2015-10-22	2017-04-27	Modernatx, Inc.	Nucleic acid vaccines for varicella zoster virus (vzv)
IL286493B (en)	2015-11-06	2022-07-01	Memorial Sloan Kettering Cancer Center	Triterpene saponin analogs, methods for their production, preparations containing them and their uses
CN110167587A (en)	2016-11-11	2019-08-23	摩登纳特斯有限公司	Influenza vaccines
CN110035772B (en) *	2016-11-25	2023-07-18	财团法人牧岩生命科学研究所	Varicella Zoster Virus Vaccine
WO2018097642A1 (en) *	2016-11-25	2018-05-31	재단법인 목암생명과학연구소	Varicella zoster virus vaccine
CN107022559A (en) *	2016-12-08	2017-08-08	长春祈健生物制品有限公司	A kind of preparation method of varicellazoster virus glycoprotein E extracellular region protein
GB201621686D0 (en)	2016-12-20	2017-02-01	Glaxosmithkline Biologicals Sa	Novel methods for inducing an immune response
CA3048608C (en) *	2016-12-26	2021-11-23	Mogam Institute For Biomedical Research	Herpes zoster vaccine composition
CN108727503A (en) *	2017-04-18	2018-11-02	武汉博沃生物科技有限公司	VZV recombinates gE- flagellum plain fusion proteins and its preparation method and application
AU2018258070A1 (en)	2017-04-25	2019-10-24	Adjuvance Technologies, Inc.	Triterpene saponin analogues
WO2018200656A1 (en) *	2017-04-25	2018-11-01	Adjuvance Technologies, Inc.	Triterpene saponin analogues
US20210187098A1 (en)	2017-04-28	2021-06-24	Glaxosmithkline Biologicals Sa	Vaccination
GB201707700D0 (en)	2017-05-12	2017-06-28	Glaxosmithkline Biologicals Sa	Dried composition
GB2600654B (en)	2017-05-30	2022-11-02	Glaxosmithkline Biologicals Sa	Novel devices
WO2019079160A1 (en)	2017-10-16	2019-04-25	Adjuvance Technologies, Inc.	Triterpene saponin analogues
WO2019106192A1 (en)	2017-12-01	2019-06-06	Glaxosmithkline Biologicals Sa	Saponin purification
CN108315344A (en) *	2018-02-14	2018-07-24	武汉博沃生物科技有限公司	VZV glycoprotein E genes expression vector and its restructuring yeast strains and application
KR102337922B1 (en)	2018-04-19	2021-12-09	가천대학교 산학협력단	Pharmaceutical composition for inhibiting varicella-zoster virus comprising compounds isolated from Elaeocarpus sylvestris extract as an active ingradient
KR20190121956A (en)	2018-04-19	2019-10-29	가천대학교 산학협력단	Pharmaceutical composition for inhibiting varicella-zoster virus comprising compounds isolated from Elaeocarpus sylvestris extract as an active ingradient
BR112020023642A2 (en) *	2018-05-23	2021-02-17	Mogam Institute For Biomedical Research	variant of varicella zoster virus antigen and use of it
EP3833382A1 (en)	2018-08-07	2021-06-16	GlaxoSmithKline Biologicals S.A.	Processes and vaccines
CN108992667A (en) *	2018-08-09	2018-12-14	安徽智飞龙科马生物制药有限公司	A kind of shingles zoster vaccine and preparation method thereof, application
KR102270048B1 (en) *	2020-07-10	2021-06-28	주식회사 녹십자	Method for production of surface protein antigen of varicella zoster virus
WO2020063370A2 (en) *	2018-09-27	2020-04-02	武汉博沃生物科技有限公司	Immune composition, preparation method therefor, and application thereof
WO2020109365A1 (en)	2018-11-29	2020-06-04	Glaxosmithkline Biologicals Sa	Methods for manufacturing an adjuvant
CN109602901B (en) *	2019-01-08	2022-05-27	成都迈科康生物科技有限公司	Herpes zoster virus vaccine and preparation method and application thereof
WO2020190750A1 (en)	2019-03-15	2020-09-24	Modernatx, Inc.	Hiv rna vaccines
JP7640473B2 (en)	2019-06-05	2025-03-05	グラクソスミスクラインバイオロジカルズソシエテアノニム	Saponin Purification
CN112142828B (en) *	2019-06-28	2022-02-01	怡道生物科技(苏州)有限公司	gE gene and vector for expressing the gene
CN112138153B (en) *	2019-06-28	2022-08-23	怡道生物科技(苏州)有限公司	Recombinant herpes zoster vaccine composition and application thereof
AU2020403296B2 (en) *	2019-12-13	2025-03-06	Grand Theravac Life Science (Nanjing) Co., Ltd.	Immunostimulatory composition and use thereof
WO2021172971A1 (en) *	2020-02-28	2021-09-02	(주)셀트리온	Varicella zoster virus fusion protein and immunogenic composition comprising same
KR20230013237A (en)	2020-03-09	2023-01-26	다이나박스 테크놀로지 코퍼레이션	Herpes zoster vaccine containing a TLR9 agonist
AU2021321944A1 (en)	2020-08-07	2023-04-06	Access To Advanced Health Institute	Purified saponins and chromatographic process for purification of same
KR102660479B1 (en) *	2020-09-11	2024-04-25	주식회사 유바이오로직스	Vaccine composition for chicken pox or herpes zoster and method using the same
RU2750818C1 (en) *	2020-11-19	2021-07-05	Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова	Viral strain for obtaining attenuated live culture vaccine for prevention and treatment of herpes zoster for adult population
WO2023056912A1 (en) *	2021-10-08	2023-04-13	Suzhou Abogen Biosciences Co., Ltd.	Nucleic acid vaccines for vzv
US20240366754A1 (en)	2021-10-15	2024-11-07	BioNTech SE	Pharmaceutical compositions for delivery of viral antigens and related methods
CA3238370A1 (en)	2021-11-24	2023-06-01	Flagship Pioneering Innovations Vi, Llc	Varicella-zoster virus immunogen compositions and their uses
CN116327912A (en) *	2021-12-23	2023-06-27	上海泽润生物科技有限公司	Herpes zoster vaccine composition
CN116350770B (en) *	2021-12-28	2024-07-12	成都迈科康生物科技有限公司	A herpes zoster vaccine preparation and preparation method thereof
CN119912535A (en) *	2021-12-28	2025-05-02	成都迈科康生物科技有限公司	HPV antigen and related products
EP4558170A1 (en)	2022-07-19	2025-05-28	GlaxoSmithKline Biologicals S.A.	Continuous process for vaccine production
CN116655748B (en) *	2023-02-28	2024-07-26	易慧生物技术(上海)有限公司	Truncated varicella-zoster virus gE protein and application thereof
CN118240844B (en) *	2024-05-27	2024-12-13	北京悦康科创医药科技股份有限公司	Herpes zoster mRNA vaccine and preparation method and application thereof
WO2026006687A1 (en) *	2024-06-28	2026-01-02	Orbital Therapeutics, Inc.	Circular rna compositions and uses thereof for diseases caused by varicella-zoster virus
CN120081913B (en) *	2025-05-08	2025-08-12	江苏华诺泰生物医药科技有限公司	A method for purifying recombinant herpes zoster virus stock solution

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5341202B2 (en)	1974-03-12	1978-11-01
US4436727A (en)	1982-05-26	1984-03-13	Ribi Immunochem Research, Inc.	Refined detoxified endotoxin product
SE8205892D0 (en)	1982-10-18	1982-10-18	Bror Morein	IMMUNOGENT MEMBRANE PROTEIN COMPLEX, SET FOR PREPARATION AND USE THEREOF
US4769239A (en)	1984-08-21	1988-09-06	Merck & Co., Inc.	Vaccine against varicella-zoster virus
US5057540A (en)	1987-05-29	1991-10-15	Cambridge Biotech Corporation	Saponin adjuvant
CA1331443C (en)	1987-05-29	1994-08-16	Charlotte A. Kensil	Saponin adjuvant
US4912094B1 (en)	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
DK0405867T3 (en)	1989-06-27	1995-05-22	Smithkline Beecham Biolog	Hitherto unknown compounds
EP0468520A3 (en)	1990-07-27	1992-07-01	Mitsui Toatsu Chemicals, Inc.	Immunostimulatory remedies containing palindromic dna sequences
ZA929870B (en)	1991-12-23	1993-08-18	Duphar Int Res	Adjuvants
CA2138997C (en)	1992-06-25	2003-06-03	Jean-Paul Prieels	Vaccine composition containing adjuvants
WO1994002596A1 (en)	1992-07-17	1994-02-03	Merck & Co., Inc.	Method for preventing zoster or alleviating varicella related post-herpetic neuralgia
SG48309A1 (en)	1993-03-23	1998-04-17	Smithkline Beecham Biolog	Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a
US5976552A (en) *	1995-04-28	1999-11-02	Protein Sciences Corporation	Virus vaccines
GB9326253D0 (en)	1993-12-23	1994-02-23	Smithkline Beecham Biolog	Vaccines
WO1996002555A1 (en)	1994-07-15	1996-02-01	The University Of Iowa Research Foundation	Immunomodulatory oligonucleotides
AUPM873294A0 (en)	1994-10-12	1994-11-03	Csl Limited	Saponin preparations and use thereof in iscoms
MX9707021A (en) *	1995-03-23	1997-11-29	Immunex Corp	Il-17 receptor.
UA56132C2 (en) *	1995-04-25	2003-05-15	Смітклайн Бічем Байолоджікалс С.А.	Vaccine composition (variants), method for stabilizing qs21 providing resistance against hydrolysis (variants), method for manufacturing vaccine
US6846489B1 (en)	1995-04-25	2005-01-25	Smithkline Beecham Biologicals S.A.	Vaccines containing a saponin and a sterol
KR0177323B1 (en) *	1996-02-16	1999-04-01	성재갑	Human diploid lung cells useful for virus vaccine production and method for preparing chickenpox vaccine using the same
ES2227825T3 (en)	1997-04-01	2005-04-01	Corixa Corporation	WATERPROOF ADVANCING IMMUNOLOGICAL COMPOSITIONS OF MONOFOSFORIL LIPIDO
GB9718901D0 (en)	1997-09-05	1997-11-12	Smithkline Beecham Biolog	Vaccine
AU1145699A (en)	1997-09-05	1999-03-22	Smithkline Beecham Biologicals (Sa)	Oil in water emulsions containing saponins
GB9901254D0 (en) *	1999-01-20	1999-03-10	Smithkline Beecham Biolog	Vaccines
HU229642B1 (en) *	2000-10-18	2014-03-28	Glaxosmithkline Beecham Biolog S A	Vaccines against cancers
GB0504436D0 (en) *	2005-03-03	2005-04-06	Glaxosmithkline Biolog Sa	Vaccine

2005
- 2005-03-03 GB GBGB0504436.7A patent/GB0504436D0/en not_active Ceased
2006
- 2006-03-01 MX MX2007010626A patent/MX2007010626A/en active IP Right Grant
- 2006-03-01 SI SI200632265T patent/SI2281831T1/en unknown
- 2006-03-01 DK DK10188214.0T patent/DK2281830T3/en active
- 2006-03-01 DK DK10188215.7T patent/DK2301955T3/en active
- 2006-03-01 CA CA2600905A patent/CA2600905C/en not_active Expired - Lifetime
- 2006-03-01 ES ES10188215.7T patent/ES2675054T3/en not_active Expired - Lifetime
- 2006-03-01 ES ES06707446.8T patent/ES2532803T3/en not_active Expired - Lifetime
- 2006-03-01 AR ARP060100773A patent/AR052498A1/en not_active Application Discontinuation
- 2006-03-01 TW TW095106863A patent/TWI403517B/en not_active IP Right Cessation
- 2006-03-01 PL PL10188214T patent/PL2281830T3/en unknown
- 2006-03-01 PE PE2010000522A patent/PE20100658A1/en not_active Application Discontinuation
- 2006-03-01 ES ES10188214.0T patent/ES2618037T3/en not_active Expired - Lifetime
- 2006-03-01 EA EA200701632A patent/EA011884B1/en not_active IP Right Cessation
- 2006-03-01 NZ NZ561075A patent/NZ561075A/en not_active IP Right Cessation
- 2006-03-01 PL PL10188215T patent/PL2301955T3/en unknown
- 2006-03-01 DK DK10188256.1T patent/DK2281831T3/en active
- 2006-03-01 DK DK06707446.8T patent/DK1858917T3/en active
- 2006-03-01 LT LTEP10188256.1T patent/LT2281831T/en unknown
- 2006-03-01 HR HRP20150142TT patent/HRP20150142T1/en unknown
- 2006-03-01 EP EP20060707446 patent/EP1858917B8/en not_active Expired - Lifetime
- 2006-03-01 MX MX2012004471A patent/MX346865B/en unknown
- 2006-03-01 UA UAA200709537A patent/UA94900C2/en unknown
- 2006-03-01 MY MYPI20060879A patent/MY148464A/en unknown
- 2006-03-01 HU HUE10188215A patent/HUE038468T2/en unknown
- 2006-03-01 SI SI200632138A patent/SI2281830T1/en unknown
- 2006-03-01 PT PT101882561T patent/PT2281831T/en unknown
- 2006-03-01 TR TR2018/09393T patent/TR201809393T4/en unknown
- 2006-03-01 HU HUE10188256A patent/HUE038467T2/en unknown
- 2006-03-01 EP EP10188256.1A patent/EP2281831B1/en not_active Expired - Lifetime
- 2006-03-01 PL PL06707446T patent/PL1858917T3/en unknown
- 2006-03-01 KR KR1020137034242A patent/KR20140006115A/en not_active Withdrawn
- 2006-03-01 EP EP10188215.7A patent/EP2301955B1/en not_active Expired - Lifetime
- 2006-03-01 BR BRPI0607840-0A patent/BRPI0607840B1/en active IP Right Grant
- 2006-03-01 SI SI200631890T patent/SI1858917T1/en unknown
- 2006-03-01 PT PT101882157T patent/PT2301955T/en unknown
- 2006-03-01 CA CA2882255A patent/CA2882255C/en not_active Expired - Lifetime
- 2006-03-01 AU AU2006222225A patent/AU2006222225B2/en active Active
- 2006-03-01 LT LTEP10188215.7T patent/LT2301955T/en unknown
- 2006-03-01 PL PL10188256T patent/PL2281831T3/en unknown
- 2006-03-01 CN CN2006800152455A patent/CN101189254B/en not_active Expired - Lifetime
- 2006-03-01 US US11/817,175 patent/US20080171079A1/en not_active Abandoned
- 2006-03-01 KR KR1020077022672A patent/KR101357204B1/en not_active Expired - Lifetime
- 2006-03-01 HU HUE10188214A patent/HUE032544T2/en unknown
- 2006-03-01 WO PCT/EP2006/002070 patent/WO2006094756A2/en not_active Ceased
- 2006-03-01 CN CN201210552767.6A patent/CN103028113B/en not_active Expired - Lifetime
- 2006-03-01 PE PE2006000237A patent/PE20061287A1/en not_active Application Discontinuation
- 2006-03-01 PT PT67074468T patent/PT1858917E/en unknown
- 2006-03-01 PT PT101882140T patent/PT2281830T/en unknown
- 2006-03-01 TR TR2018/09397T patent/TR201809397T4/en unknown
- 2006-03-01 LT LTEP10188214.0T patent/LT2281830T/en unknown
- 2006-03-01 ES ES10188256.1T patent/ES2675055T3/en not_active Expired - Lifetime
- 2006-03-01 EP EP10188214.0A patent/EP2281830B1/en not_active Expired - Lifetime
- 2006-03-01 SI SI200632264T patent/SI2301955T1/en unknown
- 2006-03-01 JP JP2007557447A patent/JP5420842B2/en not_active Expired - Lifetime
2007
- 2007-08-22 IL IL185442A patent/IL185442A/en active IP Right Grant
- 2007-08-23 ZA ZA200707144A patent/ZA200707144B/en unknown
- 2007-08-29 NO NO20074392A patent/NO341841B1/en active Protection Beyond IP Right Term
- 2007-09-24 MA MA30239A patent/MA29714B1/en unknown
2010
- 2010-05-20 US US12/784,296 patent/US20110045059A1/en not_active Abandoned
2011
- 2011-01-07 US US12/986,928 patent/US7939084B1/en active Active
2013
- 2013-04-08 JP JP2013080447A patent/JP5840167B2/en not_active Expired - Lifetime
2015
- 2015-02-20 CY CY20151100179T patent/CY1116108T1/en unknown
2017
- 2017-01-03 AR ARP170100008A patent/AR107285A2/en not_active Application Discontinuation
- 2017-01-18 HR HRP20170081TT patent/HRP20170081T1/en unknown
- 2017-02-10 CY CY20171100188T patent/CY1118629T1/en unknown
2018
- 2018-06-19 CY CY20181100636T patent/CY1121211T1/en unknown
- 2018-06-19 CY CY20181100637T patent/CY1120347T1/en unknown
- 2018-06-26 HR HRP20180989TT patent/HRP20180989T1/en unknown
- 2018-06-26 HR HRP20180988TT patent/HRP20180988T1/en unknown
- 2018-09-17 CY CY2018025C patent/CY2018025I1/en unknown
- 2018-09-20 NL NL300951C patent/NL300951I2/en unknown
- 2018-09-20 LU LU00087C patent/LUC00087I2/fr unknown
- 2018-09-20 BE BE2018C035C patent/BE2018C035I2/fr unknown
- 2018-09-20 LT LTPA2018012C patent/LTC2281831I2/en unknown
- 2018-09-20 NO NO2018033C patent/NO2018033I1/en unknown
- 2018-09-20 HU HUS1800038C patent/HUS1800038I1/en unknown
- 2018-09-20 FR FR18C1040C patent/FR18C1040I2/en active Active

Also Published As

Publication number	Publication date
KR20140006115A (en)	2014-01-15
GB0504436D0 (en)	2005-04-06
CN103028113A (en)	2013-04-10
NO2018033I1 (en)	2018-09-20
SI2281831T1 (en)	2018-07-31
LUC00087I2 (en)	2018-11-26
BRPI0607840A2 (en)	2009-06-13
BRPI0607840B1 (en)	2021-06-29
SI2281830T1 (en)	2017-03-31
EP2281830B1 (en)	2016-12-21
FR18C1040I2 (en)	2019-09-20
PT2281830T (en)	2017-02-24
TR201809397T4 (en)	2018-07-23
UA94900C2 (en)	2011-06-25
WO2006094756A2 (en)	2006-09-14
PT2281831T (en)	2018-06-15
EP2301955B1 (en)	2018-04-18
EA011884B1 (en)	2009-06-30
DK1858917T3 (en)	2015-02-02
ES2618037T3 (en)	2017-06-20
CY2018025I2 (en)	2018-12-12
LT2281831T (en)	2018-07-10
EP2281830A3 (en)	2012-01-25
WO2006094756A3 (en)	2007-02-15
TWI403517B (en)	2013-08-01
PT2301955T (en)	2018-06-18
HRP20170081T1 (en)	2017-03-24
LTPA2018012I1 (en)	2018-11-12
NZ561075A (en)	2009-06-26
HRP20180988T1 (en)	2018-08-10
ES2675055T3 (en)	2018-07-06
IL185442A0 (en)	2008-01-06
CA2600905A1 (en)	2006-09-14
EP2281831A3 (en)	2011-11-16
EA200701632A1 (en)	2008-02-28
KR20070110413A (en)	2007-11-16
PE20061287A1 (en)	2006-12-07
US7939084B1 (en)	2011-05-10
TW200643028A (en)	2006-12-16
CY1116108T1 (en)	2017-02-08
HK1111427A1 (en)	2008-08-08
PL2301955T3 (en)	2018-08-31
TR201809393T4 (en)	2018-07-23
HUE038467T2 (en)	2018-10-29
JP5840167B2 (en)	2016-01-06
EP1858917B8 (en)	2015-05-06
HUS1800038I1 (en)	2018-10-29
CY1121211T1 (en)	2020-05-29
CY2018025I1 (en)	2018-12-12
EP1858917A2 (en)	2007-11-28
AU2006222225B2 (en)	2012-08-16
PL2281830T3 (en)	2017-06-30
JP2008531637A (en)	2008-08-14
CN101189254A (en)	2008-05-28
US20110104260A1 (en)	2011-05-05
PL2281831T3 (en)	2018-08-31
PE20100658A1 (en)	2010-10-23
DK2281831T3 (en)	2018-06-14
CA2600905C (en)	2015-05-05
CN101189254B (en)	2013-05-22
US20080171079A1 (en)	2008-07-17
AR052498A1 (en)	2007-03-21
HUE032544T2 (en)	2017-10-30
CA2882255A1 (en)	2006-09-14
CY1118629T1 (en)	2017-07-12
EP2301955A2 (en)	2011-03-30
NO341841B1 (en)	2018-02-05
ZA200707144B (en)	2009-11-25
CA2882255C (en)	2018-03-27
US20110045059A1 (en)	2011-02-24
PT1858917E (en)	2015-02-24
DK2301955T3 (en)	2018-06-14
CN103028113B (en)	2015-05-20
MY148464A (en)	2013-04-30
HRP20180989T1 (en)	2018-08-10
MX2007010626A (en)	2007-10-16
HRP20150142T1 (en)	2015-05-22
ES2675054T3 (en)	2018-07-06
ES2532803T3 (en)	2015-03-31
HUE038468T2 (en)	2018-10-29
DK2281830T3 (en)	2017-03-20
EP2281830A2 (en)	2011-02-09
LTC2281831I2 (en)	2020-08-25
CY1120347T1 (en)	2018-12-12
JP2013144710A (en)	2013-07-25
EP1858917B1 (en)	2014-12-24
EP2281831B1 (en)	2018-04-18
NO20074392L (en)	2007-11-27
MA29714B1 (en)	2008-09-01
NL300951I2 (en)	2020-08-31
LT2281830T (en)	2017-02-10
EP2281831A2 (en)	2011-02-09
SI2301955T1 (en)	2018-07-31
MX346865B (en)	2017-04-04
PL1858917T3 (en)	2015-05-29
KR101357204B1 (en)	2014-02-06
NL300951I1 (en)	2018-09-26
EP2301955A3 (en)	2011-11-16
IL185442A (en)	2013-07-31
AU2006222225A1 (en)	2006-09-14
LT2301955T (en)	2018-07-10
JP5420842B2 (en)	2014-02-19
AR107285A2 (en)	2018-04-18
FR18C1040I1 (en)	2018-11-02
SI1858917T1 (en)	2015-03-31

Publication	Publication Date	Title
BE2025C533I2 (en)	2026-02-02
BE2023C529I2 (en)	2025-09-05
BE2021C552I2 (en)	2026-01-14
BE2021C557I2 (en)	2026-01-14
BE2021C524I2 (en)	2025-12-10
BE2021C519I2 (en)	2025-12-10
BE2020C531I2 (en)	2025-09-05
BE2020C511I2 (en)	2025-09-05
BE2020C508I2 (en)	2025-12-10
BE2019C521I2 (en)	2025-12-10
BE2019C503I2 (en)	2025-12-10
BE2018C037I2 (en)	2025-12-10
LUC00087I2 (en)	2018-11-26
BE2018C019I2 (en)	2026-02-02
BE2017C028I2 (en)	2025-09-10
BE2019C533I2 (en)	2025-12-10
BE2017C007I2 (en)	2026-02-02
BE2018C028I2 (en)	2025-09-05
BE2016C045I2 (en)	2026-02-02
BE2016C022I2 (en)	2026-02-02
BE2015C074I2 (en)	2025-12-10
BE2014C012I2 (en)	2026-01-14
BE2014C057I2 (en)	2025-12-10
BE2013C074I2 (en)	2025-09-17
BE2013C073I2 (en)	2026-02-02